Literature DB >> 20519510

Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes.

Christina Guzzo1, Nor Fazila Che Mat, Katrina Gee.   

Abstract

IL-27 is a heterodimeric cytokine bridging innate and adaptive immunity by playing a role in the activation of naive T cells and in development of Th1 cells. Additionally, recent evidence supports a role for IL-27 in the activation of monocytic cells. Both pro-inflammatory and anti-inflammatory activities have been attributed to IL-27; however, the role played by IL-27 in the activation of human monocytic cells in terms of cytokine production has not been well described. Our results show that IL-27 is a strong inducer of proinflammatory cytokine and chemokine expression, including enhancement of IL-6, IP-10, MIP-1alpha, MIP-1beta, and TNF-alpha expression in human primary monocytes. Furthermore, we observed that IL-27-induced cytokine and chemokine production was mediated by STAT1, STAT3, and NF-kappaB activation. Understanding how IL-27 exerts its effects on monocytic cells will identify important molecular mechanisms in the regulation of immune responses, particularly in the modulation of monocyte activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519510      PMCID: PMC2915676          DOI: 10.1074/jbc.M110.112599

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1.

Authors:  Dominik Rückerl; Manuela Hessmann; Takayuki Yoshimoto; Stefan Ehlers; Christoph Hölscher
Journal:  Immunobiology       Date:  2006-07-05       Impact factor: 3.144

2.  Conjugated linoleic acid prevents cell growth and cytokine production induced by TPA in human keratinocytes NCTC 2544.

Authors:  Germana Martinasso; Silvia Saracino; Marina Maggiora; Manuela Oraldi; Rosa A Canuto; Giuliana Muzio
Journal:  Cancer Lett       Date:  2009-06-21       Impact factor: 8.679

3.  Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.

Authors:  L F Stancato; M David; C Carter-Su; A C Larner; W B Pratt
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

4.  EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.

Authors:  Stefan Wirtz; Christoph Becker; Massimo C Fantini; Edward E Nieuwenhuis; Ingrid Tubbe; Peter R Galle; Hans-Jörg Schild; Mark Birkenbach; Richard S Blumberg; Markus F Neurath
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

6.  A preferential p110alpha/gamma PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-kappaB-dependent manner.

Authors:  Nilesh M Dagia; Gautam Agarwal; Divya V Kamath; Anshu Chetrapal-Kunwar; Ravindra D Gupte; Mahesh G Jadhav; Shruta S Dadarkar; Jacqueline Trivedi; Asha A Kulkarni-Almeida; Firuza Kharas; Lyle C Fonseca; Sanjay Kumar; Mandar R Bhonde
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-20       Impact factor: 4.249

7.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.

Authors:  M Aste-Amezaga; X Ma; A Sartori; G Trinchieri
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

8.  The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Andrea L F Bernardino; Deepak Kaushal; Mario T Philipp
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

9.  IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3.

Authors:  Céline Molle; Muriel Nguyen; Véronique Flamand; Joelle Renneson; François Trottein; Dominique De Wit; Fabienne Willems; Michel Goldman; Stanislas Goriely
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  48 in total

1.  A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins.

Authors:  Julia Diegelmann; Torsten Olszak; Burkhard Göke; Richard S Blumberg; Stephan Brand
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

Review 2.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

3.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

4.  The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.

Authors:  Joo-Yong Jung; Lawton L Roberts; Cory M Robinson
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

5.  Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.

Authors:  Alena Moudra; Sona Hubackova; Veronika Machalova; Marketa Vancurova; Jiri Bartek; Milan Reinis; Zdenek Hodny; Anna Jonasova
Journal:  Oncoimmunology       Date:  2016-05-13       Impact factor: 8.110

Review 6.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

7.  IL-27 enhances LPS-induced IL-1β in human monocytes and murine macrophages.

Authors:  Carlene Petes; Christopher Wynick; Christina Guzzo; Divya Mehta; Sarah Logan; Bruce W Banfield; Sameh Basta; Andrea Cooper; Katrina Gee
Journal:  J Leukoc Biol       Date:  2017-04-04       Impact factor: 4.962

Review 8.  The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.

Authors:  Jessica L Geiger; Jennifer R Grandis; Julie E Bauman
Journal:  Oral Oncol       Date:  2015-12-28       Impact factor: 5.337

Review 9.  Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection.

Authors:  Sanjay Swaminathan; Lue Dai; H Clifford Lane; Tomozumi Imamichi
Journal:  Cytokine Growth Factor Rev       Date:  2013-08-17       Impact factor: 7.638

Review 10.  Immunity to infection in IL-17-deficient mice and humans.

Authors:  Sophie Cypowyj; Capucine Picard; László Maródi; Jean-Laurent Casanova; Anne Puel
Journal:  Eur J Immunol       Date:  2012-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.